# INTREPID FAMILY OFFICE LLC

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1596197. Source: https://holderbook.com/funds/1596197-intrepid-family-office-llc/

- Reported value: $135.2M
- Positions: 35
- Weight of the ten largest: 69.3%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| SPDR GOLD TR | [GLD](https://holderbook.com/stocks/GLD/) | $33.2M | 40,000 | 24.5% | 5 |
| VANGUARD INDEX FDS | [VTI](https://holderbook.com/stocks/VTI/) | $14.8M | 40,000 | 10.9% | 8 |
| ISHARES BITCOIN TRUST ETF | [IBIT](https://holderbook.com/stocks/IBIT/) | $8.3M | 0 | 6.2% | 1 |
| ADAMS DIVERSIFIED EQUITY FD | [ADX](https://holderbook.com/stocks/ADX/) | $7.1M | 278,226 | 5.3% | 15 |
| NXP SEMICONDUCTORS N V | [NXPI](https://holderbook.com/stocks/NXPI/) | $6.5M | 23,200 | 4.8% | 15 |
| ASML HLDG NV | [ASML](https://holderbook.com/stocks/ASML/) | $5.5M | 2,750 | 4.0% | 7 |
| VANECK ETF TRUST | [GDXJ](https://holderbook.com/stocks/GDXJ/) | $4.9M | 50,000 | 3.6% | 5 |
| ISHARES TR | [IEF](https://holderbook.com/stocks/IEF/) | $4.7M | 50,000 | 3.5% | 1 |
| SYNOPSYS INC | [SNPS](https://holderbook.com/stocks/SNPS/) | $4.5M | 10,000 | 3.3% | 4 |
| LISTED FDS TR | [INFL](https://holderbook.com/stocks/INFL/) | $4.2M | 85,000 | 3.1% | 15 |
| ABRDN PLATINUM ETF TRUST | [PPLT](https://holderbook.com/stocks/PPLT/) | $4.2M | 300,000 | 3.1% | 5 |
| VANGUARD INTL EQUITY INDEX F | [VEU](https://holderbook.com/stocks/VEU/) | $4.2M | 50,000 | 3.1% | 6 |
| ADAM NAT RES FD INC | [PEO](https://holderbook.com/stocks/PEO/) | $3.9M | 159,066 | 2.9% | 15 |
| STATE STR SPDR S&amp;P 500 ETF T | [SPY](https://holderbook.com/stocks/SPY/) | $3.7M | 5,000 | 2.8% | 1 |
| HEARTFLOW INC | [HTFL](https://holderbook.com/stocks/HTFL/) | $3.2M | 110,000 | 2.4% | 2 |
| SLR INVESTMENT CORP | [SLRC](https://holderbook.com/stocks/SLRC/) | $3.0M | 240,000 | 2.2% | 15 |
| ROYCE SMALL CAP TRUST INC | [RVT](https://holderbook.com/stocks/RVT/) | $2.9M | 155,643 | 2.1% | 5 |
| ABRDN SILVER ETF TRUST | [SIVR](https://holderbook.com/stocks/SIVR/) | $2.8M | 50,000 | 2.1% | 7 |
| BLACKROCK SCIENCE &amp; TECHNOLO | [BSTZ](https://holderbook.com/stocks/BSTZ/) | $2.4M | 80,000 | 1.8% | 7 |
| SCHWAB CHARLES CORP | [SCHW](https://holderbook.com/stocks/SCHW/) | $1.8M | 20,000 | 1.4% | 2 |
| ROCKET COS INC | [RKT](https://holderbook.com/stocks/RKT/) | $1.6M | 100,000 | 1.2% | 1 |
| SURO CAPITAL CORP | [NSLR](https://holderbook.com/stocks/NSLR/) | $1.3M | 100,000 | 0.9% | 15 |
| LESAKA TECHNOLOGIES INC | [LSAK](https://holderbook.com/stocks/LSAK/) | $1.2M | 250,000 | 0.9% | 15 |
| FREEPORT-MCMORAN INC | [FCX](https://holderbook.com/stocks/FCX/) | $943.4K | 15,000 | 0.7% | 2 |
| INVESCO ACTIVELY MANAGED EXC | [GSY](https://holderbook.com/stocks/GSY/) | $752.2K | 15,000 | 0.6% | 1 |
| NATERA INC | [NTRA](https://holderbook.com/stocks/NTRA/) | $678.6K | 2,500 | 0.5% | 11 |
| ISHARES TR | [HEWJ](https://holderbook.com/stocks/HEWJ/) | $645.2K | 10,000 | 0.5% | 3 |
| NICE LTD | [NICE](https://holderbook.com/stocks/NICE/) | $545.1K | 6,000 | 0.4% | 1 |
| HAWAIIAN ELEC INDS INC MTN B | [HE](https://holderbook.com/stocks/HE/) | $405.9K | 30,000 | 0.3% | 6 |
| ISHARES INC | [ECH](https://holderbook.com/stocks/ECH/) | $397.0K | 10,000 | 0.3% | 2 |
| C4 THERAPEUTICS INC | [CCCC](https://holderbook.com/stocks/CCCC/) | $303.6K | 65,000 | 0.2% | 7 |
| BETA BIONICS INC | [BBNX](https://holderbook.com/stocks/BBNX/) | $235.1K | 15,000 | 0.2% | 1 |
| EDAP TMS S A | [FOCL](https://holderbook.com/stocks/FOCL/) | $129.5K | 25,000 | 0.1% | 7 |
| ORGANOGENESIS HLDGS INC | [ORGO](https://holderbook.com/stocks/ORGO/) | $110.2K | 45,350 | 0.1% | 12 |
| KALTURA INC | [KLTR](https://holderbook.com/stocks/KLTR/) | $69.0K | 53,100 | 0.1% | 2 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +7.6% | +14.8% | -7.2% | 93% |
| Q1 2026 | +2.2% | -4.6% | +6.8% | 100% |
| Q4 2025 | +8.4% | +2.4% | +6.0% | 100% |
| Q3 2025 | +10.2% | +7.8% | +2.3% | 100% |
| Q2 2025 | +4.6% | +10.5% | -5.8% | 100% |
| Q1 2025 | -1.8% | -4.6% | +2.8% | 100% |
| Q4 2023 | +8.2% | +11.2% | -2.9% | 99% |
| Q3 2023 | -3.4% | -3.6% | +0.2% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $135.2M | 35 |
| Q1 2026 | $123.6M | 37 |
| Q4 2025 | $116.0M | 38 |
| Q3 2025 | $119.6M | 37 |
| Q2 2025 | $122.1M | 39 |
| Q1 2025 | $71.1M | 31 |
| Q4 2024 | $96.0M | 34 |
| Q3 2023 | $62.4M | 27 |
| Q2 2023 | $52.5M | 25 |
| Q1 2023 | $45.6M | 23 |
| Q4 2022 | $39.9M | 22 |
| Q3 2022 | $33.0M | 20 |

